Anna Granata
Overview
Explore the profile of Anna Granata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
85
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Granata A, Mejri O, Rizzi F
Springerplus
. 2016 Nov;
5(1):1874.
PMID: 27822447
Background: The family-school relationship is a crucial component in achieving the optimum scholastic experience of pupils. Such a relationship is often described in somewhat reductive binary terms of collaboration/non-collaboration. However,...
2.
Bagnoli M, Granata A, Nicoletti R, Krishnamachary B, Bhujwalla Z, Canese R, et al.
Front Oncol
. 2016 Jul;
6:153.
PMID: 27446799
Compared with normal differentiated cells, cancer cells require a metabolic reprograming to support their high proliferation rates and survival. Aberrant choline metabolism is a fairly new metabolic hallmark reflecting the...
3.
Bagnoli M, De Cecco L, Granata A, Nicoletti R, Marchesi E, Alberti P, et al.
Oncotarget
. 2015 May;
6(12):9643.
PMID: 26002433
No abstract available.
4.
Granata A, Nicoletti R, Perego P, Iorio E, Krishnamachary B, Benigni F, et al.
Oncotarget
. 2015 Mar;
6(13):11216-30.
PMID: 25796169
Epithelial Ovarian Cancer (EOC) "cholinic phenotype", characterized by increased intracellular phosphocholine content sustained by over-expression/activity of choline kinase-alpha (ChoKα/CHKA), is a metabolic cellular reprogramming involved in chemoresistance with still unknown...
5.
Bagnoli M, De Cecco L, Granata A, Nicoletti R, Marchesi E, Alberti P, et al.
Oncotarget
. 2012 Jan;
2(12):1265-78.
PMID: 22246208
A major challenge in advanced-stage epithelial ovarian cancer (EOC) is prediction of chemoresistant relapse. Our aim was to identify a microRNA (miRNA) signature associated with early relapse in advanced-stage EOC...